Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.175 AUD | 0.00% | -2.78% | -2.78% |
Apr. 23 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
Apr. 10 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
Sales 2024 * | 11.81M 7.8M | Sales 2025 * | 17.97M 11.86M | Capitalization | 78.37M 51.73M |
---|---|---|---|---|---|
Net income 2024 * | -17M -11.22M | Net income 2025 * | -16M -10.56M | EV / Sales 2024 * | 4.9 x |
Net cash position 2024 * | 20.45M 13.5M | Net cash position 2025 * | 17.07M 11.27M | EV / Sales 2025 * | 3.41 x |
P/E ratio 2024 * |
-4.49
x | P/E ratio 2025 * |
-4.57
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.75% |
1 week | -2.78% | ||
Current month | -5.41% | ||
1 month | -2.78% | ||
3 months | +12.90% | ||
6 months | -18.60% | ||
Current year | -2.78% |
Managers | Title | Age | Since |
---|---|---|---|
Luke Reid
CEO | Chief Executive Officer | - | - |
James Heath
DFI | Director of Finance/CFO | - | - |
Yao Liu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Capone
BRD | Director/Board Member | 61 | 21-03-17 |
Director/Board Member | - | 22-09-07 | |
Hyung-Tae Kim
BRD | Director/Board Member | 61 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.175 | 0.00% | 16,000 |
24-05-09 | 0.175 | -2.78% | 19,744,300 |
24-05-08 | 0.18 | 0.00% | 3,000 |
24-05-07 | 0.18 | 0.00% | 95 |
24-05-06 | 0.18 | 0.00% | 43,700 |
Delayed Quote Australian S.E., May 09, 2024 at 08:04 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.78% | 51.75M | |
-16.58% | 8.49B | |
+58.90% | 4.08B | |
-39.78% | 2.42B | |
-10.33% | 2.42B | |
-8.91% | 2.33B | |
-2.53% | 2.01B | |
-19.90% | 1.53B | |
-38.30% | 1.26B | |
+2.19% | 1.07B |
- Stock Market
- Equities
- MAP Stock